Pathogen Discovery in the Post-COVID Era
Pathogens · 05.01.2024 · 13 (1) · 51
DOI: 10.3390/pathogens13010051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 05.01.2024. Verfasst von Cheng Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology, the Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology.
Abstract (Originalsprache)
Pathogen discovery plays a crucial role in the fields of infectious diseases, clinical microbiology, and public health. During the past four years, the global response to the COVID-19 pandemic highlighted the importance of early and accurate identification of novel pathogens for effective management and prevention of outbreaks. The post-COVID era has ushered in a new phase of infectious disease research, marked by accelerated advancements in pathogen discovery. This review encapsulates the recent innovations and paradigm shifts that have reshaped the landscape of pathogen discovery in response to the COVID-19 pandemic. Primarily, we summarize the latest technology innovations, applications, and causation proving strategies that enable rapid and accurate pathogen discovery for both acute and historical infections. We also explored the significance and the latest trends and approaches being employed for effective implementation of pathogen discovery from various clinical and environmental samples. Furthermore, we emphasize the collaborative nature of the pandemic response, which has led to the establishment of global networks for pathogen discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
- School of Public Health, Xinjiang Medical University, Urumqi 830017, China.
ORCID-Profile: Cheng Guo, Jian-Yong Wu
Förderung
- Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology
- the Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology
Zitieren
APA
Guo, C., & Wu, J. Y. (2024). Pathogen Discovery in the Post-COVID Era. Pathogens, 13(1), 51. https://doi.org/10.3390/pathogens13010051
Vancouver
Guo C, Wu JY. Pathogen Discovery in the Post-COVID Era. Pathogens. 2024;13(1):51. doi:10.3390/pathogens13010051
BibTeX
@article{Guo2024,
author = {Guo, Cheng and Wu, Jian-Yong},
title = {Pathogen Discovery in the Post-COVID Era},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {1},
pages = {51},
doi = {10.3390/pathogens13010051}
}
EUVIMED